Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number.
Herr
Harry W
HW
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
D002291:Carcinoma, Papillary / Q000473:pathology* / Q000628:therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000628:therapy; D012449:Safety; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000628:therapy